ImmunityBio Inc.

IBRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.34

+$0.89 (+10.53%)

Sep 22, 2026, 1:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-351.47M	-413.65M	-583.85M	-416.57M	-346.79M	-224.19M
Depreciation & Amortization	15.53M	17.55M	18.51M	34.54M	14.3M	12.74M
Stock-Based Compensation	36.81M	34.43M	49.16M	40.18M	57.18M	2.19M
Other Working Capital	-7.6M	-5.62M	10.3M	-16M	-15.4M	13.79M
Other Non-Cash Items	48.53M	-10.16M	145.44M	20.34M	16.29M	24.12M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	-2.94M
Change in Working Capital	-54.33M	-19.42M	3.83M	-16M	-15.4M	16.36M
Operating Cash Flow	-304.94M	-391.24M	-366.76M	-337.51M	-274.42M	-171.72M
Capital Expenditures	-3.85M	-6.89M	-30.58M	-78.16M	-33.56M	-1.67M
Cash Acquisitions	n/a	-1M	n/a	n/a	n/a	8K
Purchase of Investments	-241.37M	-140.22M	-10.36M	n/a	n/a	-91.77M
Sales Maturities Of Investments	95.82M	136.61M	10.47M	n/a	n/a	73.62M
Other Investing Acitivies	n/a	-747K	n/a	105.46M	-51.32M	-8K
Investing Cash Flow	-149.8M	-12.25M	-30.47M	27.3M	-84.89M	-19.81M
Debt Repayment	1.72M	96.89M	451.39M	174.07M	338.5M	63.7M
Common Stock Repurchased	n/a	n/a	n/a	-616K	-4.06M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.27M	73.38M	-3.44M	60.16M	171.01M	673K
Financial Cash Flow	400.24M	281.63M	558.34M	233.61M	505.44M	150.68M
Net Cash Flow	-54.48M	-121.88M	160.82M	-76.32M	146.19M	-40.89M
Free Cash Flow	-308.78M	-398.12M	-397.34M	-415.67M	-307.98M	-173.39M
Adj. Free Cash Flow	-345.59M	-432.56M	-446.5M	-455.85M	-365.16M	-175.58M
Maintenance CapEx	n/a	n/a	n/a	-78.16M	n/a	n/a
Growth CapEx	-3.85M	-6.89M	-30.58M	n/a	-33.56M	-1.67M
Owner Earnings	-304.94M	-391.24M	-366.76M	-415.67M	-274.42M	-171.72M